Analyst consensus rating
Encompass Health Analyst Rating: Strong Buy
Direct answer
Encompass Health's consensus rating is Strong Buy.
12 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $156.08.
Forecast evidence checked November 10, 2026.
Get free Encompass Health email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $142.51
- Average price target
- $156.08
- High price target
- $177.00
- Low price target
- $142.00
- Low target gap
- -0.4%
- Target upside
- +9.5%
- High target gap
- +24.2%
- Target range width
- 24.6%
- Consensus rating
- Strong Buy
- Analysts
- 12
- Evidence date
- November 10, 2026
- Valid through
- November 17, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Encompass Health?
Encompass Health has a verified Strong Buy consensus. The same dataset has an average price target of $156.08.
How far are Encompass Health's low and high targets from the recorded price?
The low target implies -0.4%, while the high target implies +24.2%.
How many analysts are included in Encompass Health's consensus?
The verified consensus includes 12 analysts.
How is Encompass Health's target upside or downside calculated?
The average target of $156.08 is divided by the recorded price of $142.51, then one is subtracted to produce +9.5%. This does not guarantee a future return.
When was Encompass Health's analyst forecast verified?
The data was verified on 2026-11-10. The dataset is valid through 2026-11-17.